Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

por Hashida, Shinsuke, Yamamoto, Hiromasa, Shien, Kazuhiko, Miyoshi, Yuichiro, Ohtsuka, Tomoaki, Suzawa, Ken, Watanabe, Mototsugu, Maki, Yuho, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2015

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations

por Suzawa, Ken, Toyooka, Shinichi, Sakaguchi, Masakiyo, Morita, Mizuki, Yamamoto, Hiromasa, Tomida, Shuta, Ohtsuka, Tomoaki, Watanabe, Mototsugu, Hashida, Shinsuke, Maki, Yuho, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Miyoshi, Shinichiro
Publicado 2015

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway

por Ohtsuka, Tomoaki, Sakaguchi, Masakiyo, Yamamoto, Hiromasa, Tomida, Shuta, Takata, Katsuyoshi, Shien, Kazuhiko, Hashida, Shinsuke, Miyata-Takata, Tomoko, Watanabe, Mototsugu, Suzawa, Ken, Soh, Junichi, Youyi, Chen, Sato, Hiroki, Namba, Kei, Torigoe, Hidejiro, Tsukuda, Kazunori, Yoshino, Tadashi, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2016